Skip to content

泰利医疗

US · TDOC #3241 按市值排名 上市于 2015
5.67 -0.30 -5.03%
实时 - 追踪5344个代码 - 心跳于569秒前 · 2026-10-16 20:01

✦ 量化股权信号 计算方式说明

涨跌不一/平稳
  • 机构持股总比例基本持平。

机构持股

机构持股比例
84.67% +0.05pp
机构数量
413
数据截至
2026/Q3 较上一报告期

持股变动 vs 资金流向

方向一致

机构在上一报告期增持了股份，同时该股在最近20个交易日的主力资金呈净流入——两者方向一致。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund59.59%
Hedge Fund17.95%
Public Company3.12%
Private Company2.10%
VC/PE Fund1.10%
Individual/Insider0.69%
Government Pension Fund0.40%
Insurance Company0.26%
Family Office/Trust0.10%
Other14.68%

主要股东 截至 2026-06-30

BlackRock 8.93% · 16.22M 股
Vanguard Portfolio Management, LLC 6.98% · 12.69M 股
Vanguard Capital Management, LLC 5.04% · 9.15M 股
Point72 Asset Management, L.P. 4.54% · 8.24M 股
Renaissance Technologies Corp. 4.44% · 8.07M 股
Voss Capital, LP 4.43% · 8.05M 股
Dimensional Fund Advisors 4.06% · 7.37M 股
State Street Global Advisors 2.73% · 4.96M 股
American Century Investment Management 2.69% · 4.89M 股
Pacific Investment Management Company LLC 2.57% · 4.67M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 17次买入 · 33次卖出

姓名职务持股比例
Charles Divita Chief Executive Officer 0.26%
David Snow Independent Non-Executive Chairperson 0.09%
Mala Murthy Chief Financial Officer 0.08%
Adam Vandervoort Chief Legal Officer 0.06%
Kelly Bliss President of U.S. Group Health 0.05%
Catherine Jacobson Independent Director 0.04%
Carlos Nueno President of International 0.04%
David Shedlarz Independent Director 0.03%
Sandra Fenwick Independent Director 0.02%
Joseph Catapano Chief Accounting Officer 0.01%

内部人交易 最近的 Form 4 申报记录

日期姓名职务类型股数价格
2026-10-01 Joseph Catapano Chief Accounting Officer Derivative Exercise and Sale -655 $5.65
2026-09-30 Joseph Catapano Chief Accounting Officer Derivative Exercise and Retained +1,428 --
2026-09-10 Charles Divita Chief Executive Officer Derivative Exercise and Sale -17,805 $6.10
2026-09-10 Charles Divita Chief Executive Officer Intent to Sell (Form 144) -17,805 $6.10
2026-09-09 Charles Divita Chief Executive Officer Derivative Exercise and Retained +24,997 --
2026-09-02 Fernando Madeira President of BetterHelp Derivative Exercise and Sale -15,251 $6.30–6.51
2026-09-02 Fernando Madeira President of BetterHelp Intent to Sell (Form 144) -9,812 $6.51
2026-09-01 Charles Divita Chief Executive Officer Derivative Exercise and Sale -18,327 $6.30
2026-09-01 Charles Divita Chief Executive Officer Intent to Sell (Form 144) -18,327 $6.30
2026-09-01 Joseph Catapano Chief Accounting Officer Derivative Exercise and Sale -274 $6.30
2026-09-01 Adam Vandervoort Chief Legal Officer Derivative Exercise and Sale -7,573 $6.30
2026-09-01 Adam Vandervoort Chief Legal Officer Intent to Sell (Form 144) -7,573 $6.30
2026-09-01 Fernando Madeira President of BetterHelp Intent to Sell (Form 144) -5,439 $6.30
2026-09-01 Kelly Bliss President of U.S. Group Health Derivative Exercise and Sale -7,357 $6.30
2026-09-01 Kelly Bliss President of U.S. Group Health Intent to Sell (Form 144) -7,357 $6.30
2026-09-01 Carlos Nueno President of International Derivative Exercise and Sale -6,200 $6.30
2026-09-01 Carlos Nueno President of International Intent to Sell (Form 144) -6,200 $6.30
2026-08-31 Charles Divita Chief Executive Officer Derivative Exercise and Retained +25,916 --
2026-08-31 Joseph Catapano Chief Accounting Officer Derivative Exercise and Retained +598 --
2026-08-31 Michael Grasher Chief Financial Officer Other Derivative Acquisition +239,616 --

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 20:01:10 · 仅供参考，不构成投资建议，也未考虑您的具体情况。

泰利医疗 讨论区 0 条评论

发表评论